Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

2.650 -0.080 (-2.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 267,381
Open 2.700
Bid (Size) 2.650 (100)
Ask (Size) 2.790 (100)
Prev. Close 2.730
Today's Range 2.610 - 2.715
52wk Range 2.150 - 8.770
Shares Outstanding 38,063,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Quanterix (QTRX) Q2 2026 Earnings Call Transcript ↗
Revenue guidance slashed as commercial execution stumbles and academic spending weakens. 
Via The Motley Fool
Topics Earnings
News headline image
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test ↗
Quanterix (NASDAQ:QTRX) CEO Everett Cunningham said the company is repositioning its commercial organization and investing in diagnostics and clinical-trial capabilities following the integration of... 
Via MarketBeat

Performance

YTD
-58.8%
-58.8%
1 Month
+9.5%
+9.5%
3 Month
-13.7%
-13.7%
6 Month
-47.1%
-47.1%
1 Year
-38.2%
-38.2%

More News

Read More
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
Quanterix (NASDAQ:QTRX) Beats Q1 2026 EPS Estimates Despite Revenue Miss ↗
Via Chartmill
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
Via Chartmill
Here are the top movers in Monday's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
News headline image
Quanterix Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Quanterix Names Jim Gute Chief Commercial Officer
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Financial Results for the Second Quarter of 2026
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
News headline image
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From Quanterix
Via Business Wire
News headline image
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Planned Transition of Chief Financial Officer
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix (QTRX) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Quanterix Releases Financial Results for the First Quarter of 2026
From Quanterix Corporation
Via Business Wire
News headline image
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows
From Quanterix
Via Business Wire

Frequently Asked Questions

Is Quanterix Corporation - Common Stock publicly traded?
Yes, Quanterix Corporation - Common Stock is publicly traded.
What exchange does Quanterix Corporation - Common Stock trade on?
Quanterix Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Quanterix Corporation - Common Stock?
The ticker symbol for Quanterix Corporation - Common Stock is QTRX on the Nasdaq Stock Market
What is the current price of Quanterix Corporation - Common Stock?
The current price of Quanterix Corporation - Common Stock is 2.650
When was Quanterix Corporation - Common Stock last traded?
The last trade of Quanterix Corporation - Common Stock was at 09/09/26 04:00 PM ET
What is the market capitalization of Quanterix Corporation - Common Stock?
The market capitalization of Quanterix Corporation - Common Stock is 100.87M
How many shares of Quanterix Corporation - Common Stock are outstanding?
Quanterix Corporation - Common Stock has 101M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.